Koers Vcanbio Cell & Gene Engineering Corp., Ltd
Aandelen
600645
CNE000000545
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,64 CNY | +1,43% | +0,19% | -22,84% |
Omzet 2021 | 1,54 mld. 212 mln. 199 mln. | Omzet 2022 | 1,55 mld. 215 mln. 201 mln. | Marktkapitalisatie | 7,96 mld. 1,1 mld. 1,03 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 155 mln. 21,39 mln. 20,06 mln. | Nettowinst (verlies) 2022 | 113 mln. 15,59 mln. 14,62 mln. | EV/omzet 2021 | 6,97 x |
Nettoliquiditeiten 2021 | 1,11 mld. 154 mln. 144 mln. | Nettoliquiditeiten 2022 | 1,25 mld. 173 mln. 162 mln. | EV/omzet 2022 | 4,31 x |
K/w-verhouding 2021 |
76,5
x | K/w-verhouding 2022 |
70,9
x | Werknemers | 2.332 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 72,17% |
1 dag | +1,43% | ||
1 week | +0,19% | ||
Lopende maand | -4,63% | ||
1 maand | -7,29% | ||
3 maanden | -6,29% | ||
6 maanden | -13,50% | ||
Lopend jaar | -22,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 30-06-09 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 25-05-22 |
Hai Bin Li
BRD | Director/Board Member | 53 | 01-02-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 30-06-09 |
Xin Yi Hou
BRD | Director/Board Member | 64 | 19-05-20 |
Hong Qi Wang
BRD | Director/Board Member | 59 | 16-05-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +1,63% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 15,64 | +1,43% | 4 008 999 |
19-04-24 | 15,42 | -0,90% | 2 871 144 |
18-04-24 | 15,56 | -0,45% | 4 608 400 |
17-04-24 | 15,63 | +3,58% | 5 457 000 |
16-04-24 | 15,09 | -3,33% | 6 561 005 |
slotkoers Shanghai S.E., 22 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-22,84% | 1,01 mld. | |
+1,29% | 12,66 mld. | |
-17,03% | 7,04 mld. | |
+2,40% | 5,39 mld. | |
-2,51% | 4,45 mld. | |
+1,73% | 4,32 mld. | |
-50,32% | 3,31 mld. | |
+6,90% | 2,6 mld. | |
-16,69% | 2,01 mld. | |
-3,40% | 1,67 mld. |